1. Biosimilars Market Executive Summary2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Type
6.3. Segmentation By Application
7. Biosimilars Market Characteristics
7.1. Market Definition
7.2. Segmentation By Type
7.2.1. Monoclonal Antibodies
7.2.2. Insulin
7.2.3. Erythropoietin
7.2.4. Granulocyte-Colony Stimulating Factor
7.2.5. Other Hormone
7.2.6. Others
7.3. Segmentation By Application
7.3.1. Oncology
7.3.2. Chronic and Autoimmune Diseases
7.3.3. Growth Hormone Deficiency
7.3.4. Infectious Diseases
7.3.5. Others
8. Biosimilars Market Trends And Strategies
8.1. Robust Research & Development
8.2. Demand For Biosimilars In The Treatment Of Neutropenia
8.3. Growing Mergers And Acquisitions
8.4. Revised FDA Regulations To Facilitate Biosimilar Drug Development
8.5. Large Number Of Strategic Partnerships
8.6. Increasing Investments In Biosimilars Market
9. Impact Of COVID-19 On The Biosimilars Market
9.1. Clinical Trial Delays
9.2. Impact On Major Biosimilars Companies In The Market
9.3. Impact On Rituximab Biosimilars
9.4. How Leading Rituximab Biosimilars Companies Handled COVID
9.5. Impact Of COVID-19 On Major Pegfilgrastim Biosimilar Market Player Biocon Biologics
9.6. Future Outlook
10. Global Biosimilars Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)
10.2.1. Drivers Of The Market 2015 – 2020
10.2.2. Restraints On The Market 2015 – 2020
10.3.Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
10.3.1. Drivers Of The Market 2020 – 2025
10.3.2. Restraints On The Market 2020 – 2025
11. Global Biosimilars Market Segmentation
11.1. Global Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
11.2. Global Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
12. Biosimilars Market, Regional And Country Analysis
12.1. Global Biosimilars Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
12.2. Global Biosimilars Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13. Asia-Pacific Biosimilars Market
13.1. Asia-Pacific Biosimilars Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. Background Information
13.1.4. Government Initiatives
13.1.5. Regulatory Bodies
13.1.6. Regulations
13.1.7. Major Associations
13.1.8. Taxes Levied
13.1.9. Corporate Tax Structure
13.1.10. Investments
13.1.11. Major Companies
13.2. Asia-Pacific Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.3. Asia-Pacific Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
13.4.Asia-Pacific Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.5. Asia-Pacific Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.6.Asia-Pacific Biosimilars Market: Country Analysis
13.7. China Biosimilars Market
13.8.China Biosimilars Market Overview
13.8.1. Country Information
13.8.2. Market Information
13.8.3. Background Information
13.8.4. Government Initiatives
13.8.5. Regulatory Bodies
13.8.6. Regulations
13.8.7. Major Associations
13.8.8. Taxes Levied
13.8.9. Corporate Tax Structure
13.8.10. Investments
13.8.11. Major Companies
13.9.China Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.10. China Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
13.11. China Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.12. China Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.13. India Biosimilars Market
13.14. India Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.15. India Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
13.16. India Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.17. India Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.18. Japan Biosimilars Market
13.19. Japan Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.20. Japan Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
13.21. Japan Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.22. Japan Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.23. Australia Biosimilars Market
13.24. Australia Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.25. Australia Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
13.26. Australia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.27. Australia Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.28. Indonesia Biosimilars Market
13.29. Indonesia Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.30. Indonesia Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
13.31. Indonesia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.32. Indonesia Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.33. South Korea Biosimilars Market
13.34. South Korea Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.35. South Korea Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
13.36. South Korea Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.37. South Korea Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14. Western Europe Biosimilars Market
14.1.Western Europe Biosimilars Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. Background Information
14.1.4. Government Initiatives
14.1.5. Regulatory Bodies
14.1.6. Regulations
14.1.7. Major Associations
14.1.8. Taxes Levied
14.1.9. Corporate Tax Structure
14.1.10. Investments
14.1.11. Major Companies
14.2. Western Europe Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.3.Western Europe Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
14.4. Western Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.5. Western Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.6. Western Europe Biosimilars Market: Country Analysis
14.7. UK Biosimilars Market
14.8. UK Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.9. UK Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
14.10. UK Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.11. UK Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.12. Germany Biosimilars Market
14.13. Germany Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.14. Germany Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
14.15. Germany Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.16. Germany Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.17. France Biosimilars Market
14.18. France Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.19. France Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
14.20. France Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.21. France Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15. Eastern Europe Biosimilars Market
15.1. Eastern Europe Biosimilars Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Background Information
15.1.4. Government Initiatives
15.1.5. Regulatory Bodies
15.1.6. Regulations
15.1.7. Taxes Levied
15.1.8. Corporate Tax Structure
15.1.9. Investments
15.1.10. Major Companies
15.2. Eastern Europe Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
15.3. Eastern Europe Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
15.4. Eastern Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.5. Eastern Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.6. Eastern Europe Biosimilars Market: Country Analysis
15.7. Russia Biosimilars Market
15.8. Russia Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
15.9. Russia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.10. Russia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16. North America Biosimilars Market
16.1.North America Biosimilars Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. Background Information
16.1.4. Government Initiatives
16.1.5. Regulatory Bodies
16.1.6. Regulations
16.1.7. Major Associations
16.1.8. Taxes Levied
16.1.9. Corporate tax structure
16.1.10. Investments
16.1.11. Major Companies
16.2. North America Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
16.3.North America Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
16.4. North America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16.5. North America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16.6. North America Biosimilars Market: Country Analysis
16.7. USA Biosimilars Market
16.8. USA Biosimilars Market Overview
16.8.1. Country Information
16.8.2. Market Information
16.8.3. Background Information
16.8.4. Government Initiatives
16.8.5. Regulatory Bodies
16.8.6. Regulations
16.8.7. Major Associations
16.8.8. Taxes Levied
16.8.9. Corporate Tax Structure
16.8.10.Investments
16.8.11. Major Companies
16.9. USA Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
16.10. USA Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
16.11. USA Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16.12. USA Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17. South America Biosimilars Market
17.1. South America Biosimilars Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Background Information
17.1.4. Government Initiatives
17.1.5. Regulatory Bodies
17.1.6. Regulations
17.1.7. Major Associations
17.1.8. Taxes Levied
17.1.9. Corporate Tax Structure
17.1.10. Investments
17.1.11. Major Companies
17.2. South America Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
17.3. South America Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
17.4. South America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.5. South America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.6. South America Biosimilars Market: Country Analysis
17.7. Brazil Biosimilars Market
17.8. Brazil Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
17.9. Brazil Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.10. Brazil Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18. Middle East Biosimilars Market
18.1. Middle East Biosimilars Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background information
18.1.4. Government Initiatives
18.1.5. Regulatory Bodies
18.1.6. Regulations
18.1.7. Major Associations
18.1.8. Taxes Levied
18.1.9. Corporate Tax Structure
18.1.10. Investments
18.1.11. Major Companies
18.2. Middle East Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.3.Middle East Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
18.4. Middle East Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.5. Middle East Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19. Africa Biosimilars Market
19.1.Africa Biosimilars Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background information
19.1.4. Government Initiatives
19.1.5. Regulatory Bodies
19.1.6. Regulations
19.1.7. Major Associations
19.1.8. Taxes Levied
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Africa Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.3.Africa Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
19.4. Africa Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.5. Africa Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20. Biosimilars Market Competitive Landscape
20.1. Company Profiles
20.2. Amgen Inc.
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. Pfizer Inc.
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Novartis AG
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. Viatris Inc.
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Celltrion, Inc.
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview
21. Key Mergers And Acquisitions In The Biosimilars Market
21.1. Celltrion Acquired Takeda Pharmaceuticals
21.2. ChrysCapital Acquired Stakes In Intas Pharmaceuticals
21.3. Amgen Acquired Japanese JV with Astellas
21.4. True North Acquired Stake In Biocon Biologics Ltd.
21.5. PAG Acquired Hisun BioRay Bio-pharmaceutical Co., Ltd.
21.6. Pfizer Inc. Acquired Array BioPharma Inc.
21.7. Samsung Bioepis Enters Into An Agreement With C-Bridge Capital
21.8. Fuji Pharma Co., Ltd. Acquired Stake In Alvotech
21.9. Kashiv Pharma Acquired Adello Biologics
21.10. Bristol-Myers Squibb Acquired Celgene Corporation
21.11. Takeda Pharmaceutical Company Limited Acquired Shire Plc
21.12. Amneal Pharmaceuticals Merge With Impax Laboratories
21.13. Biocon Merged With Sandoz
21.14. Sun Pharmaceutical Industries Limited Acquired Zenotech Laboratories
22. Biosimilars Market Opportunities And Strategies
22.1. Global Biosimilars Market In 2025 – Countries Offering Most New Opportunities
22.2. Global Biosimilars Market In 2025 – Segments Offering Most New Opportunities
22.3. Global Biosimilars Market In 2025 – Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies
23. Biosimilars Market, Conclusions And Recommendations
23.1. Conclusions
23.2. Recommendations
23.2.1. Product
23.2.2. Place
23.2.3. Price
23.2.4. Promotion
23.2.5. People
24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. The Business Research Company
24.6. Copyright and Disclaimer